Patents by Inventor Carlota Vinals Bassols

Carlota Vinals Bassols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the production of immunogenic compositions
    Patent number: 8597656
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: December 3, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • PROCESS FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS
    Publication number: 20120269835
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Application
    Filed: December 13, 2011
    Publication date: October 25, 2012
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • MAGE3 polypeptides
    Patent number: 8097257
    Abstract: The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: January 17, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Cabezon Sil Va, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • Process for the production of immunogenic compositions
    Patent number: 8044183
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: October 25, 2011
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • MAGE3 Polypeptides
    Publication number: 20100209444
    Abstract: The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof.
    Type: Application
    Filed: December 17, 2009
    Publication date: August 19, 2010
    Inventors: TERESA CABEZON SIL VA, JOSEPH COHEN, MONCEF MOHAMED SLAOUI, CARLOTA VINALS BASSOLS
  • Process for the Production of Immunogenic Compositions
    Publication number: 20100204458
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Application
    Filed: March 12, 2010
    Publication date: August 12, 2010
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols